Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $9.01 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 45.20.
Market Cap
9.01T
Revenue
4.59T
Profits
199.3B
PE Ratio
45.20
Profit Margin
4.34%
Dividend Yield
0.39%
1056 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.10T | 1.81% | 3,652,155 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 622.29B | 1.51% | 8,404,680 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 449.31B | 0.38% | 9,362,241 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 381.26B | -1.89% | 5,160,859 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 319.55B | 0.56% | 9,554,976 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 293.79B | 1.35% | 1,609,550 | 60.44B |
| 7 | NVS | Novartis AG | 285.79B | 1.40% | 2,263,448 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 213.15B | 0.56% | 8,263,416 | 50.57B |
| 9 | AMGN | Amgen Inc. | 194.59B | 0.62% | 2,414,655 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 188.20B | -1.29% | 2,040,650 | 45.20B |
| 11 | ABT | Abbott Laboratories | 161.48B | -1.50% | 10,350,611 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 156.85B | -1.21% | 6,628,908 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 143.78B | 0.31% | 2,307,081 | 10.58B |
| 14 | PFE | Pfizer Inc. | 138.90B | 0.33% | 46,201,419 | 63.32B |
| 15 | DHR | Danaher Corporation | 136.44B | -1.74% | 2,755,755 | 24.78B |
| 16 | CVS | CVS Health Corporation | 132.16B | -0.73% | 4,786,969 | 405.62B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 126.81B | 1.69% | 1,980,967 | 12.22B |
| 18 | SYK | Stryker Corporation | 126.71B | -0.66% | 2,799,563 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 119.58B | 1.81% | 11,715,870 | 48.48B |
| 20 | GSK | GSK plc | 104.43B | 0.59% | 4,183,145 | 43.29B |
| 21 | MDT | Medtronic plc | 103.59B | -0.06% | 8,482,876 | 36.36B |
| 22 | SNY | Sanofi | 103.49B | 1.12% | 2,809,535 | 54.60B |
| 23 | MCK | McKesson Corporation | 87.52B | -2.09% | 1,419,195 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 87.03B | 0.17% | 1,185,419 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 84.27B | -1.81% | 1,222,681 | 200.42B |
| 26 | CI | The Cigna Group | 73.74B | -1.43% | 1,352,005 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 64.63B | -1.70% | 16,321,627 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 64.28B | -0.17% | 715,117 | 14.92B |
| 29 | ARGX | argenx SE | 55.63B | 2.85% | 270,129 | 4.74B |
| 30 | CAH | Cardinal Health, Inc. | 55.32B | -0.71% | 1,917,482 | 250.74B |
| 31 | COR | Cencora, Inc. | 54.80B | -1.57% | 782,947 | 328.68B |
| 32 | EW | Edwards Lifesciences Corporation | 52.50B | 0.44% | 3,498,310 | 6.30B |
| 33 | MDLN | Medline Inc. | 52.04B | 1.90% | 8,346,228 | 29.14B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 50.50B | 0.44% | 3,657,839 | 28.34B |
| 35 | HUM | Humana Inc. | 46.69B | 1.32% | 1,191,521 | 137.20B |
| 36 | BDX | Becton, Dickinson and Company | 42.76B | -0.47% | 2,356,842 | 22.23B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 42.28B | -2.82% | 799,312 | 4.45B |
| 38 | RVMD | Revolution Medicines, Inc. | 40.95B | 5.79% | 5,311,443 | - |
| 39 | HLN | Haleon plc | 40.69B | 0.97% | 8,722,346 | 14.85B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.19B | 0.74% | 1,357,851 | 4.29B |
| 41 | NTRA | Natera, Inc. | 39.00B | 3.97% | 1,614,630 | 2.50B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 38.79B | 0.30% | 3,249,091 | 17.35B |
| 43 | A | Agilent Technologies, Inc. | 37.52B | -2.34% | 1,943,203 | 7.23B |
| 44 | WAT | Waters Corporation | 36.22B | -1.48% | 956,743 | 3.77B |
| 45 | ALC | Alcon Inc. | 32.91B | -0.28% | 1,857,763 | 10.63B |
| 46 | RPRX | Royalty Pharma plc | 32.89B | 1.58% | 2,480,338 | 2.44B |
| 47 | IQV | IQVIA Holdings Inc. | 32.26B | 1.12% | 1,291,751 | 16.63B |
| 48 | ONC | BeOne Medicines AG | 32.17B | 3.40% | 315,158 | 5.70B |
| 49 | BIIB | Biogen Inc. | 31.98B | 0.28% | 1,238,474 | 9.94B |
| 50 | CNC | Centene Corporation | 31.87B | -1.81% | 4,023,867 | 178.33B |
| 51 | ZTS | Zoetis Inc. | 30.71B | -3.73% | 6,525,421 | 9.53B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 29.59B | -1.08% | 3,905,613 | 20.98B |
| 53 | RMD | ResMed Inc. | 28.66B | -0.93% | 1,390,938 | 5.54B |
| 54 | VEEV | Veeva Systems Inc. | 28.63B | 2.84% | 3,287,185 | 3.32B |
| 55 | MRNA | Moderna, Inc. | 27.66B | 3.61% | 7,918,360 | 2.23B |
| 56 | ILMN | Illumina, Inc. | 27.40B | 2.58% | 1,202,583 | 4.39B |
| 57 | DXCM | DexCom, Inc. | 27.00B | -0.23% | 2,666,774 | 4.82B |
| 58 | PHG | Koninklijke Philips N.V. | 25.91B | 0.41% | 779,034 | 20.34B |
| 59 | MTD | Mettler-Toledo International Inc. | 25.44B | -0.39% | 239,817 | 4.09B |
| 60 | WST | West Pharmaceutical Services, Inc. | 25.06B | 1.09% | 683,750 | 3.22B |
| 61 | ROIV | Roivant Sciences Ltd. | 24.98B | 1.94% | 6,384,190 | 8.26M |
| 62 | BNTX | BioNTech SE | 23.84B | 3.33% | 928,663 | 3.23B |
| 63 | DGX | Quest Diagnostics Incorporated | 23.54B | 1.32% | 781,613 | 11.28B |
| 64 | UTHR | United Therapeutics Corporation | 23.13B | 0.42% | 412,279 | 3.17B |
| 65 | LH | Labcorp Holdings Inc. | 22.93B | 2.99% | 837,288 | 14.14B |
| 66 | INCY | Incyte Corporation | 22.91B | 0.80% | 1,506,112 | 5.36B |
| 67 | INSM | Insmed Incorporated | 22.70B | 1.32% | 2,737,394 | 819.56M |
| 68 | STE | STERIS plc | 20.78B | -1.13% | 678,163 | 5.94B |
| 69 | GH | Guardant Health, Inc. | 20.39B | 3.03% | 2,723,696 | 1.08B |
| 70 | VTRS | Viatris Inc. | 18.90B | -0.61% | 8,907,216 | 14.56B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 17.65B | -2.00% | 1,852,983 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 17.09B | 0.88% | 1,346,040 | 3.10B |
| 73 | ASND | Ascendis Pharma A/S | 16.38B | 1.13% | 901,594 | 998.25M |
| 74 | GMAB | Genmab A/S | 16.12B | -0.38% | 1,950,137 | 3.90B |
| 75 | THC | Tenet Healthcare Corporation | 16.12B | -0.97% | 1,118,969 | 21.46B |
| 76 | MEDP | Medpace Holdings, Inc. | 15.27B | 1.45% | 390,789 | 2.68B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 14.92B | 3.35% | 975,090 | 4.44B |
| 78 | BTSG | BrightSpring Health Services, Inc. | 14.37B | - | 3,069,934 | 13.65B |
| 79 | DVA | DaVita Inc. | 14.10B | 1.23% | 749,906 | 13.84B |
| 80 | BBIO | BridgeBio Pharma, Inc. | 14.10B | 2.52% | 2,872,817 | 579.96M |
| 81 | COO | The Cooper Companies, Inc. | 13.92B | 0.52% | 2,783,568 | 4.23B |
| 82 | EXEL | Exelixis, Inc. | 13.64B | -0.89% | 2,587,319 | 2.38B |
| 83 | SOLV | Solventum Corporation | 13.55B | -1.62% | 1,076,359 | 8.26B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 13.34B | -0.60% | 2,091,002 | 1.06B |
| 85 | ICLR | ICON Public Limited Company | 13.25B | 1.84% | 1,244,628 | 8.27B |
| 86 | SNN | Smith & Nephew plc | 12.85B | 0.80% | 1,046,449 | 6.16B |
| 87 | FMS | Fresenius Medical Care AG | 12.52B | -2.32% | 863,829 | 22.32B |
| 88 | ALGN | Align Technology, Inc. | 12.43B | -2.70% | 973,005 | 4.10B |
| 89 | AXSM | Axsome Therapeutics, Inc. | 12.41B | -0.20% | 1,338,079 | 708.24M |
| 90 | PEN | Penumbra, Inc. | 12.41B | -0.37% | 330,583 | 1.45B |
| 91 | RVTY | Revvity, Inc. | 12.41B | -1.60% | 1,997,839 | 2.90B |
| 92 | ELAN | Elanco Animal Health Incorporated | 12.36B | 0.69% | 3,100,648 | 4.89B |
| 93 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.16B | 2.85% | 446,019 | 1.13B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 12.12B | -3.38% | 4,471,177 | 3.58B |
| 95 | MOH | Molina Healthcare, Inc. | 11.96B | -0.09% | 1,124,239 | 43.10B |
| 96 | CYTK | Cytokinetics, Incorporated | 11.85B | 6.17% | 3,596,088 | 105.82M |
| 97 | GMED | Globus Medical, Inc. | 11.39B | -2.68% | 1,581,924 | 3.10B |
| 98 | BAX | Baxter International Inc. | 11.37B | -0.09% | 5,721,029 | 11.32B |
| 99 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.34B | 2.04% | 1,647,524 | 622.01M |
| 100 | KRYS | Krystal Biotech, Inc. | 11.15B | 1.58% | 286,949 | 417.30M |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 11.15B | -2.25% | 1,769,450 | 3.24B |
| 102 | SMMT | Summit Therapeutics Inc. | 11.11B | 2.21% | 5,969,742 | - |
| 103 | TECH | Bio-Techne Corporation | 11.05B | -0.14% | 13,853,921 | 1.21B |
| 104 | PODD | Insulet Corporation | 10.93B | -0.32% | 1,559,804 | 2.90B |
| 105 | CRL | Charles River Laboratories International, Inc. | 10.87B | 4.55% | 1,091,711 | 4.03B |
| 106 | TEM | Tempus AI, Inc. | 10.47B | 3.87% | 7,681,972 | 1.36B |
| 107 | EHC | Encompass Health Corporation | 10.01B | -0.42% | 876,231 | 6.07B |
| 108 | APGE | Apogee Therapeutics, Inc. | 9.94B | 0.05% | 3,048,454 | - |
| 109 | PRAX | Praxis Precision Medicines, Inc. | 9.77B | 6.95% | 586,928 | 7.46M |
| 110 | NUVL | Nuvalent, Inc. | 9.76B | -0.01% | 1,242,919 | - |
| 111 | HSIC | Henry Schein, Inc. | 9.61B | -0.71% | 1,104,726 | 13.38B |
| 112 | CORT | Corcept Therapeutics Incorporated | 9.44B | 0.65% | 831,274 | 769.10M |
| 113 | IBRX | ImmunityBio, Inc. | 9.19B | 0.69% | 14,628,635 | 140.98M |
| 114 | ENSG | The Ensign Group, Inc. | 9.17B | -2.97% | 793,519 | 5.27B |
| 115 | HALO | Halozyme Therapeutics, Inc. | 9.15B | 2.96% | 2,132,521 | 1.51B |
| 116 | BRKR | Bruker Corporation | 9.09B | -1.97% | 1,853,649 | 3.46B |
| 117 | KYMR | Kymera Therapeutics, Inc. | 8.99B | 1.11% | 1,675,461 | 51.48M |
| 118 | UHS | Universal Health Services, Inc. | 8.90B | 0.91% | 1,063,982 | 17.76B |
| 119 | OSCR | Oscar Health, Inc. | 8.87B | -1.14% | 4,600,791 | 13.30B |
| 120 | ALKS | Alkermes plc | 8.76B | -4.63% | 2,938,429 | 1.56B |
| 121 | GKOS | Glaukos Corporation | 8.35B | -1.54% | 1,243,790 | 551.35M |
| 122 | PCVX | Vaxcyte, Inc. | 8.33B | 2.12% | 2,749,993 | - |
| 123 | QGEN | Qiagen N.V. | 8.23B | 0.96% | 2,308,877 | 2.10B |
| 124 | ATR | AptarGroup, Inc. | 8.00B | -0.55% | 446,637 | 3.87B |
| 125 | IMVT | Immunovant, Inc. | 7.91B | -0.82% | 1,329,117 | - |
| 126 | BIO | Bio-Rad Laboratories, Inc. | 7.90B | -1.83% | 308,941 | 2.59B |
| 127 | TGTX | TG Therapeutics, Inc. | 7.90B | -0.20% | 1,595,153 | 700.35M |
| 128 | SYRE | Spyre Therapeutics, Inc. | 7.83B | 2.58% | 1,993,464 | - |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 7.82B | -0.28% | 739,475 | 74.06M |
| 130 | HIMS | Hims & Hers Health, Inc. | 7.73B | -1.62% | 13,984,340 | 2.37B |
| 131 | RGEN | Repligen Corporation | 7.73B | -6.81% | 1,793,100 | 763.34M |
| 132 | ABVX | ABIVAX Société Anonyme | 7.58B | -1.38% | 2,092,220 | 5.67M |
| 133 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.54B | 0.16% | 827,645 | 217.17M |
| 134 | MIRM | Mirum Pharmaceuticals, Inc. | 7.50B | -0.67% | 963,715 | 569.61M |
| 135 | HQY | HealthEquity, Inc. | 7.34B | -0.73% | 964,025 | 1.34B |
| 136 | LNTH | Lantheus Holdings, Inc. | 7.13B | -0.20% | 1,345,961 | 1.55B |
| 137 | AVTR | Avantor, Inc. | 6.85B | -2.43% | 8,630,777 | 6.55B |
| 138 | PTCT | PTC Therapeutics, Inc. | 6.77B | -3.39% | 4,327,766 | 827.11M |
| 139 | LQDA | Liquidia Corporation | 6.68B | -3.90% | 2,247,217 | 288.07M |
| 140 | COGT | Cogent Biosciences, Inc. | 6.62B | 1.68% | 3,188,116 | - |
| 141 | SRRK | Scholar Rock Holding Corporation | 6.58B | 0.31% | 2,093,308 | - |
| 142 | CGON | CG Oncology, Inc. | 6.50B | 2.46% | 1,089,418 | 5.07M |
| 143 | PACS | PACS Group, Inc. | 6.32B | -4.66% | 783,402 | 5.43B |
| 144 | HNGE | Hinge Health, Inc. | 6.30B | 3.18% | 4,338,968 | 646.34M |
| 145 | LGND | Ligand Pharmaceuticals Incorporated | 6.29B | 3.44% | 529,242 | 274.48M |
| 146 | GRFS | Grifols, S.A. | 6.27B | -0.81% | 518,871 | 8.58B |
| 147 | DFTX | Definium Therapeutics, Inc. | 6.18B | 3.56% | 4,669,689 | - |
| 148 | TWST | Twist Bioscience Corporation | 6.13B | -1.48% | 1,658,144 | 409.48M |
| 149 | BLTE | Belite Bio, Inc | 6.08B | 3.98% | 195,166 | - |
| 150 | CHE | Chemed Corporation | 6.08B | -0.73% | 115,969 | 2.54B |
| 151 | BLCO | Bausch + Lomb Corporation | 5.93B | 1.90% | 230,846 | 5.21B |
| 152 | XENE | Xenon Pharmaceuticals Inc. | 5.81B | 0.65% | 1,688,682 | 7.50M |
| 153 | ERAS | Erasca, Inc. | 5.69B | 14.24% | 7,984,635 | - |
| 154 | LEGN | Legend Biotech Corporation | 5.69B | 2.44% | 1,288,803 | 1.14B |
| 155 | TFX | Teleflex Incorporated | 5.64B | -1.83% | 286,584 | 2.13B |
| 156 | ORKA | Oruka Therapeutics, Inc. | 5.58B | 2.09% | 1,734,799 | - |
| 157 | BLLN | BillionToOne, Inc. | 5.54B | 1.89% | 601,367 | 354.54M |
| 158 | AMRX | Amneal Pharmaceuticals, Inc. | 5.52B | 0.35% | 1,746,192 | 3.05B |
| 159 | CRSP | CRISPR Therapeutics AG | 5.43B | 2.60% | 1,840,999 | 4.10M |
| 160 | TVTX | Travere Therapeutics, Inc. | 5.42B | -0.93% | 1,369,909 | 536.20M |
| 161 | DNTH | Dianthus Therapeutics, Inc. | 5.23B | 0.35% | 1,098,866 | 1.34M |
| 162 | CAI | Caris Life Sciences, Inc. | 5.18B | -0.97% | 3,115,394 | 907.29M |
| 163 | MANE | Veradermics, Incorporated | 5.16B | -2.61% | 720,787 | - |
| 164 | INDV | Indivior Pharmaceuticals, Inc. | 5.03B | -1.36% | 1,511,438 | 1.29B |
| 165 | CELC | Celcuity Inc. | 5.00B | 2.57% | 974,820 | - |
| 166 | SHC | Sotera Health Company | 5.00B | 0.81% | 2,378,162 | 1.19B |
| 167 | ALHC | Alignment Healthcare, Inc. | 4.81B | 0.30% | 4,122,500 | 4.26B |
| 168 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.80B | 5.42% | 1,508,252 | 754.05M |
| 169 | VCYT | Veracyte, Inc. | 4.80B | -0.59% | 1,469,035 | 541.74M |
| 170 | STVN | Stevanato Group S.p.A. | 4.74B | -2.69% | 254,519 | 1.39B |
| 171 | TXG | 10x Genomics, Inc. | 4.72B | 1.09% | 2,713,751 | 638.78M |
| 172 | TNGX | Tango Therapeutics, Inc. | 4.71B | 3.46% | 5,372,457 | 56.99M |
| 173 | RDNT | RadNet, Inc. | 4.67B | -2.32% | 812,454 | 2.14B |
| 174 | VKTX | Viking Therapeutics, Inc. | 4.59B | 3.94% | 2,880,006 | - |
| 175 | LIVN | LivaNova PLC | 4.56B | -0.44% | 1,050,345 | 1.43B |
| 176 | EWTX | Edgewise Therapeutics, Inc. | 4.41B | -1.23% | 1,921,807 | - |
| 177 | NVST | Envista Holdings Corporation | 4.40B | 0.22% | 2,516,336 | 2.81B |
| 178 | ACAD | ACADIA Pharmaceuticals Inc. | 4.32B | -0.47% | 1,612,364 | 1.10B |
| 179 | RLAY | Relay Therapeutics, Inc. | 4.30B | 6.36% | 4,210,578 | 10.68M |
| 180 | MMSI | Merit Medical Systems, Inc. | 4.18B | -2.29% | 836,313 | 1.54B |
| 181 | MMED | MiniMed Group, Inc. | 4.18B | 4.49% | 1,337,780 | 3.10B |
| 182 | DNLI | Denali Therapeutics Inc. | 4.11B | 1.15% | 2,163,793 | - |
| 183 | LFST | LifeStance Health Group, Inc. | 4.01B | 0.58% | 4,776,434 | 1.49B |
| 184 | NAMS | NewAmsterdam Pharma Company N.V. | 3.96B | 1.90% | 1,079,126 | 22.57M |
| 185 | RCUS | Arcus Biosciences, Inc. | 3.91B | 0.26% | 1,564,407 | 236.00M |
| 186 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.89B | 0.65% | 873,683 | 18.07M |
| 187 | IRTC | iRhythm Holdings, Inc. | 3.89B | -0.40% | 453,802 | 787.85M |
| 188 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | -0.13% | 1,729,747 | 596.96M |
| 189 | WAY | Waystar Holding Corp. | 3.83B | 0.40% | 1,812,831 | 1.16B |
| 190 | CON | Concentra Group Holdings Parent, Inc. | 3.81B | -1.36% | 1,000,467 | 2.23B |
| 191 | BKD | Brookdale Senior Living Inc. | 3.79B | 0.95% | 4,991,823 | 3.00B |
| 192 | TLX | Telix Pharmaceuticals Limited | 3.78B | 6.00% | 287,335 | 803.79M |
| 193 | DOCS | Doximity, Inc. | 3.77B | -1.39% | 5,449,175 | 644.86M |
| 194 | PBLS | Parabilis Medicines, Inc. | 3.72B | 1.35% | 556,974 | - |
| 195 | ICUI | ICU Medical, Inc. | 3.70B | -0.23% | 344,137 | 2.16B |
| 196 | WRBY | Warby Parker Inc. | 3.69B | 2.98% | 2,331,523 | 890.57M |
| 197 | GPCR | Structure Therapeutics Inc. | 3.67B | 3.98% | 712,905 | - |
| 198 | OGN | Organon & Co. | 3.56B | 0.37% | 1,432,462 | 6.16B |
| 199 | ELVN | Enliven Therapeutics, Inc. | 3.55B | 1.54% | 1,569,973 | - |
| 200 | DYN | Dyne Therapeutics, Inc. | 3.52B | 1.53% | 2,171,732 | - |
| 201 | BEAM | Beam Therapeutics Inc. | 3.48B | 0.40% | 2,611,279 | 164.01M |
| 202 | IDYA | IDEAYA Biosciences, Inc. | 3.48B | -0.52% | 1,040,169 | 225.27M |
| 203 | ALMS | Alumis Inc. | 3.46B | 2.80% | 1,700,164 | 8.40M |
| 204 | ADPT | Adaptive Biotechnologies Corporation | 3.42B | 2.10% | 3,079,253 | 295.41M |
| 205 | HAE | Haemonetics Corporation | 3.41B | -2.81% | 612,671 | 1.33B |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 3.34B | -0.96% | 1,324,059 | 415.62M |
| 207 | OPCH | Option Care Health, Inc. | 3.34B | -2.45% | 2,601,187 | 5.67B |
| 208 | QURE | uniQure N.V. | 3.26B | -0.25% | 2,300,005 | 18.09M |
| 209 | NHC | National HealthCare Corporation | 3.22B | -0.10% | 137,172 | 1.53B |
| 210 | PRVA | Privia Health Group, Inc. | 3.22B | -0.08% | 1,266,599 | 2.25B |
| 211 | VERA | Vera Therapeutics, Inc. | 3.10B | 1.63% | 3,046,400 | - |
| 212 | ITGR | Integer Holdings Corporation | 3.10B | -2.84% | 678,541 | 1.86B |
| 213 | RGC | Regencell Bioscience Holdings Limited | 3.07B | -4.48% | 367,081 | - |
| 214 | RARE | Ultragenyx Pharmaceutical Inc. | 3.01B | -0.29% | 3,551,837 | 670.00M |
| 215 | HTFL | HeartFlow, Inc. | 3.01B | -2.24% | 1,700,247 | 191.42M |
| 216 | CLDX | Celldex Therapeutics, Inc. | 2.94B | 6.18% | 1,385,883 | 865.00K |
| 217 | GRAL | GRAIL, Inc. | 2.94B | 3.75% | 399,432 | 156.12M |
| 218 | SLS | SELLAS Life Sciences Group, Inc. | 2.87B | 24.70% | 32,643,888 | - |
| 219 | IRON | Disc Medicine, Inc. | 2.85B | -0.37% | 1,454,441 | - |
| 220 | KLRA | Kailera Therapeutics, Inc. | 2.81B | 4.18% | 579,058 | - |
| 221 | CLOV | Clover Health Investments, Corp. | 2.80B | -1.85% | 7,578,636 | 2.21B |
| 222 | SUPN | Supernus Pharmaceuticals, Inc. | 2.72B | -0.09% | 941,113 | 776.83M |
| 223 | TRVI | Trevi Therapeutics, Inc. | 2.65B | 2.64% | 2,546,243 | - |
| 224 | TARS | Tarsus Pharmaceuticals, Inc. | 2.64B | -2.64% | 979,586 | 535.08M |
| 225 | ESTA | Establishment Labs Holdings Inc. | 2.57B | -1.09% | 539,190 | 229.58M |
| 226 | MBX | MBX Biosciences, Inc. | 2.56B | 2.94% | 1,059,868 | - |
| 227 | GRDN | Guardian Pharmacy Services, Inc. | 2.56B | -4.42% | 364,987 | 1.46B |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.55B | 0.98% | 2,392,675 | 3.37B |
| 229 | ABCL | AbCellera Biologics Inc. | 2.48B | 10.03% | 13,913,914 | 79.21M |
| 230 | NRIX | Nurix Therapeutics, Inc. | 2.47B | 4.15% | 2,423,057 | 71.78M |
| 231 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.43B | -3.92% | 6,528,978 | 885.72M |
| 232 | PHVS | Pharvaris N.V. | 2.43B | 2.06% | 698,930 | - |
| 233 | IMNM | Immunome, Inc. | 2.38B | 5.41% | 1,597,250 | 4.02M |
| 234 | AXGN | Axogen, Inc. | 2.38B | -0.47% | 1,089,282 | 238.11M |
| 235 | MLYS | Mineralys Therapeutics, Inc. | 2.37B | 0.75% | 1,604,805 | - |
| 236 | KOD | Kodiak Sciences Inc. | 2.36B | 5.01% | 941,184 | - |
| 237 | BFLY | Butterfly Network, Inc. | 2.33B | 0.22% | 12,939,605 | 102.92M |
| 238 | TMDX | TransMedics Group, Inc. | 2.33B | -1.68% | 1,245,030 | 635.89M |
| 239 | NTLA | Intellia Therapeutics, Inc. | 2.32B | -0.42% | 5,570,907 | 66.09M |
| 240 | KARD | Kardigan, Inc. | 2.31B | 9.75% | 1,376,051 | - |
| 241 | VCEL | Vericel Corporation | 2.31B | -2.36% | 771,590 | 292.09M |
| 242 | PBH | Prestige Consumer Healthcare Inc. | 2.28B | -2.79% | 835,386 | 1.09B |
| 243 | PGNY | Progyny, Inc. | 2.26B | 1.23% | 1,279,329 | 1.29B |
| 244 | AGIO | Agios Pharmaceuticals, Inc. | 2.26B | 0.28% | 771,182 | 66.05M |
| 245 | BHVN | Biohaven Ltd. | 2.25B | -5.56% | 3,493,796 | - |
| 246 | ASTH | Astrana Health, Inc. | 2.23B | 1.17% | 714,199 | 3.53B |
| 247 | PVLA | Palvella Therapeutics, Inc. | 2.22B | 4.47% | 324,116 | - |
| 248 | NKTR | Nektar Therapeutics | 2.21B | 2.73% | 802,718 | 55.63M |
| 249 | LMAT | LeMaitre Vascular, Inc. | 2.19B | 0.36% | 397,809 | 256.28M |
| 250 | GENB | Generate Biomedicines, Inc. | 2.17B | 2.67% | 1,701,811 | 30.30M |
| 251 | OCUL | Ocular Therapeutix, Inc. | 2.17B | 0.61% | 2,060,990 | 52.04M |
| 252 | XRAY | DENTSPLY SIRONA Inc. | 2.17B | -1.73% | 4,614,661 | 3.68B |
| 253 | AUPH | Aurinia Pharmaceuticals Inc. | 2.16B | -2.55% | 3,319,835 | 298.30M |
| 254 | TSHA | Taysha Gene Therapies, Inc. | 2.15B | 6.15% | 4,512,928 | 7.47M |
| 255 | SGRY | Surgery Partners, Inc. | 2.15B | 4.80% | 1,429,661 | 3.34B |
| 256 | PGEN | Precigen, Inc. | 2.11B | 1.02% | 6,273,128 | 31.60M |
| 257 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.08B | 5.12% | 2,370,497 | -665.00K |
| 258 | VRDN | Viridian Therapeutics, Inc. | 2.07B | 4.97% | 7,597,608 | 70.92M |
| 259 | ZLAB | Zai Lab Limited | 2.07B | 2.28% | 944,868 | 453.28M |
| 260 | WGS | GeneDx Holdings Corp. | 2.05B | -1.00% | 858,576 | 442.68M |
| 261 | SEM | Select Medical Holdings Corporation | 2.05B | 0.18% | 3,725,675 | 5.52B |
| 262 | HRMY | Harmony Biosciences Holdings, Inc. | 2.05B | -0.37% | 625,013 | 899.11M |
| 263 | UFPT | UFP Technologies, Inc. | 2.04B | 1.28% | 165,190 | 608.85M |
| 264 | CMPS | COMPASS Pathways plc | 2.03B | 1.69% | 3,586,896 | - |
| 265 | PLSE | Pulse Biosciences, Inc. | 2.02B | 2.69% | 466,469 | 751.00K |
| 266 | GLUE | Monte Rosa Therapeutics, Inc. | 2.02B | 7.22% | 1,838,202 | 42.95M |
| 267 | STOK | Stoke Therapeutics, Inc. | 2.02B | 1.22% | 488,824 | 32.08M |
| 268 | NEOG | Neogen Corporation | 1.98B | -5.01% | 2,015,897 | 870.56M |
| 269 | MD | Pediatrix Medical Group, Inc. | 1.98B | 0.04% | 581,045 | 1.93B |
| 270 | ATAI | AtaiBeckley Inc. | 1.97B | 1.32% | 10,520,123 | 3.49M |
| 271 | RXRX | Recursion Pharmaceuticals, Inc. | 1.96B | 4.83% | 22,055,417 | 66.41M |
| 272 | GHRS | GH Research PLC | 1.95B | 0.96% | 229,080 | - |
| 273 | NUVB | Nuvation Bio Inc. | 1.95B | -0.71% | 7,901,002 | 143.05M |
| 274 | SION | Sionna Therapeutics, Inc. | 1.94B | 1.87% | 306,936 | - |
| 275 | ADMA | ADMA Biologics, Inc. | 1.94B | -4.34% | 4,298,795 | 509.86M |
| 276 | LKFT | Lakefront Biotherapeutics NV | 1.93B | 0.85% | 122,617 | 1.20B |
| 277 | RAPP | Rapport Therapeutics, Inc. | 1.93B | 0.82% | 435,858 | 20.00M |
| 278 | SNDX | Syndax Pharmaceuticals, Inc. | 1.93B | 2.21% | 3,935,300 | 217.17M |
| 279 | BCAX | Bicara Therapeutics Inc. | 1.93B | 9.19% | 1,568,083 | - |
| 280 | ALMR | Alamar Biosciences, Inc. | 1.92B | 4.12% | 457,112 | 87.16M |
| 281 | ABSI | Absci Corporation | 1.92B | 4.22% | 7,637,783 | 1.84M |
| 282 | AGL | agilon health, inc. | 1.92B | -3.44% | 440,193 | 5.82B |
| 283 | ANAB | AnaptysBio, Inc. | 1.92B | 4.53% | 704,014 | 232.39M |
| 284 | TYRA | Tyra Biosciences, Inc. | 1.91B | 0.78% | 632,541 | - |
| 285 | AVAH | Aveanna Healthcare Holdings Inc. | 1.89B | - | 1,591,856 | 2.52B |
| 286 | IOVA | Iovance Biotherapeutics, Inc. | 1.88B | -0.94% | 9,940,746 | 285.61M |
| 287 | OMCL | Omnicell, Inc. | 1.86B | 1.97% | 548,956 | 1.23B |
| 288 | NEO | NeoGenomics, Inc. | 1.86B | 0.56% | 2,482,696 | 745.97M |
| 289 | SNDA | Sonida Senior Living, Inc. | 1.85B | 1.64% | 483,597 | 367.34M |
| 290 | HCM | HUTCHMED (China) Limited | 1.82B | 5.31% | 40,337 | 548.51M |
| 291 | BHC | Bausch Health Companies Inc. | 1.81B | 1.89% | 4,333,998 | 10.53B |
| 292 | NBTX | Nanobiotix S.A. | 1.80B | -0.08% | 109,630 | 38.27M |
| 293 | SRPT | Sarepta Therapeutics, Inc. | 1.80B | 1.01% | 3,797,455 | 2.18B |
| 294 | ADUS | Addus HomeCare Corporation | 1.79B | 1.13% | 320,035 | 1.45B |
| 295 | NVCR | NovoCure Limited | 1.79B | 0.26% | 1,040,854 | 674.41M |
| 296 | ANIP | ANI Pharmaceuticals, Inc. | 1.78B | -0.46% | 315,389 | 923.71M |
| 297 | TRLV | Trulieve Cannabis Corp. | 1.78B | 2.78% | 1,011,876 | 1.17B |
| 298 | ZYME | Zymeworks Inc. | 1.76B | -0.12% | 1,056,162 | 81.26M |
| 299 | URGN | UroGen Pharma Ltd. | 1.76B | 4.43% | 579,024 | 140.49M |
| 300 | VIR | Vir Biotechnology, Inc. | 1.75B | 3.49% | 1,603,797 | 65.50M |
| 301 | MESO | Mesoblast Limited | 1.74B | 3.18% | 150,825 | 65.38M |
| 302 | COAG | Hemab Therapeutics Holdings, Inc. | 1.72B | 13.47% | 361,749 | - |
| 303 | INVA | Innoviva, Inc. | 1.71B | -1.82% | 878,668 | 420.69M |
| 304 | HCSG | Healthcare Services Group, Inc. | 1.68B | 0.78% | 285,976 | 1.85B |
| 305 | AKTS | Aktis Oncology, Inc. | 1.66B | 2.19% | 539,256 | 8.28M |
| 306 | FTRE | Fortrea Holdings Inc. | 1.66B | -0.74% | 1,208,871 | 2.71B |
| 307 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.65B | 2.73% | 3,058,375 | 204.73M |
| 308 | MLTX | MoonLake Immunotherapeutics | 1.64B | 0.05% | 1,185,583 | - |
| 309 | ZBIO | Zenas BioPharma, Inc. | 1.61B | -1.24% | 1,229,157 | 10.00M |
| 310 | MAZE | Maze Therapeutics, Inc. | 1.61B | 2.00% | 771,505 | 20.00M |
| 311 | AVBP | ArriVent BioPharma, Inc. | 1.60B | 1.09% | 485,925 | - |
| 312 | INNV | InnovAge Holding Corp. | 1.58B | 7.78% | 835,910 | 949.17M |
| 313 | AAPG | Ascentage Pharma Group International | 1.58B | 5.25% | 10,878 | 82.08M |
| 314 | TDOC | Teladoc Health, Inc. | 1.57B | 3.58% | 6,378,371 | 2.51B |
| 315 | SEPN | Septerna, Inc. | 1.57B | -6.92% | 1,432,369 | 72.26M |
| 316 | MPLT | MapLight Therapeutics, Inc. | 1.56B | 3.06% | 362,022 | - |
| 317 | IMCR | Immunocore Holdings plc | 1.55B | -1.49% | 501,567 | 412.81M |
| 318 | NVAX | Novavax, Inc. | 1.54B | 5.41% | 4,034,544 | 596.34M |
| 319 | HROW | Harrow, Inc. | 1.53B | -2.19% | 482,528 | 268.68M |
| 320 | SVRA | Savara Inc. | 1.53B | 2.20% | 1,216,025 | - |
| 321 | CDNA | CareDx, Inc. | 1.51B | 1.60% | 497,978 | 412.82M |
| 322 | DMRA | Damora Therapeutics, Inc. | 1.49B | -4.53% | 520,248 | - |
| 323 | KMTS | Kestra Medical Technologies, Ltd. | 1.48B | -4.09% | 731,307 | 83.72M |
| 324 | ATEC | Alphatec Holdings, Inc. | 1.46B | 2.15% | 4,067,403 | 787.08M |
| 325 | STAA | STAAR Surgical Company | 1.46B | 0.14% | 940,317 | 290.38M |
| 326 | IART | Integra LifeSciences Holdings Corporation | 1.46B | -0.11% | 987,428 | 1.64B |
| 327 | ATRC | AtriCure, Inc. | 1.45B | -4.90% | 1,972,116 | 552.16M |
| 328 | PSNL | Personalis, Inc. | 1.44B | 5.61% | 3,769,341 | 64.52M |
| 329 | ARDT | Ardent Health, Inc. | 1.42B | 2.06% | 527,272 | 6.43B |
| 330 | INBX | Inhibrx Biosciences, Inc. | 1.40B | 0.54% | 410,665 | 1.30M |
| 331 | PRGO | Perrigo Company plc | 1.39B | 1.01% | 4,348,231 | 4.18B |
| 332 | BLFS | BioLife Solutions, Inc. | 1.38B | -1.29% | 3,407,197 | 101.66M |
| 333 | AVLN | Avalyn Pharma Inc. | 1.38B | 1.37% | 348,670 | - |
| 334 | CAPR | Capricor Therapeutics, Inc. | 1.38B | -9.98% | 3,237,413 | 11.13M |
| 335 | AHCO | AdaptHealth Corp. | 1.36B | -0.78% | 1,888,490 | 3.29B |
| 336 | XERS | Xeris Biopharma Holdings, Inc. | 1.34B | 0.65% | 2,225,022 | 314.85M |
| 337 | JBIO | Jade Biosciences, Inc. | 1.31B | 0.64% | 1,122,368 | - |
| 338 | MNKD | MannKind Corporation | 1.31B | 2.42% | 2,923,466 | 360.78M |
| 339 | IMTX | Immatics N.V. | 1.31B | 0.53% | 292,044 | 43.00M |
| 340 | SDGR | Schrödinger, Inc. | 1.30B | 3.14% | 1,951,567 | 254.91M |
| 341 | INSP | Inspire Medical Systems, Inc. | 1.29B | -1.73% | 715,382 | 915.25M |
| 342 | ARDX | Ardelyx, Inc. | 1.29B | -5.77% | 8,390,922 | 427.68M |
| 343 | PAHC | Phibro Animal Health Corporation | 1.29B | 0.38% | 389,811 | 1.50B |
| 344 | OMDA | Omada Health, Inc. | 1.29B | 3.73% | 1,771,686 | 283.30M |
| 345 | PRCT | PROCEPT BioRobotics Corporation | 1.29B | 0.09% | 1,126,608 | 322.02M |
| 346 | ENOV | Enovis Corporation | 1.27B | -3.04% | 1,352,923 | 2.28B |
| 347 | PNTG | The Pennant Group, Inc. | 1.26B | 1.20% | 309,770 | 1.02B |
| 348 | ALVO | Alvotech | 1.26B | 1.09% | 687,000 | 562.04M |
| 349 | AMN | AMN Healthcare Services, Inc. | 1.26B | -1.16% | 681,918 | 3.42B |
| 350 | QDEL | QuidelOrtho Corporation | 1.24B | 32.20% | 6,182,235 | 2.66B |
| 351 | AHG | Akso Health Group | 1.24B | -4.61% | 17,203 | 14.84M |
| 352 | CRVS | Corvus Pharmaceuticals, Inc. | 1.22B | 7.34% | 1,494,412 | - |
| 353 | SPTX | Seaport Therapeutics, Inc. | 1.21B | 5.23% | 232,077 | - |
| 354 | IRMD | IRADIMED CORPORATION | 1.20B | 0.02% | 104,568 | 86.28M |
| 355 | EYPT | EyePoint, Inc. | 1.18B | 3.29% | 1,578,094 | 7.61M |
| 356 | AZTA | Azenta, Inc. | 1.18B | 0.04% | 507,833 | 596.48M |
| 357 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.17B | 3.53% | 4,616,631 | 69.64M |
| 358 | AVNS | Avanos Medical, Inc. | 1.17B | -0.08% | 631,450 | 715.90M |
| 359 | COLL | Collegium Pharmaceutical, Inc. | 1.17B | -1.67% | 510,631 | 796.33M |
| 360 | MGTX | MeiraGTx Holdings plc | 1.16B | 3.55% | 675,115 | 79.76M |
| 361 | XNCR | Xencor, Inc. | 1.16B | 3.65% | 562,864 | 97.36M |
| 362 | NUTX | Nutex Health Inc. | 1.15B | 0.72% | 197,400 | 879.95M |
| 363 | OPK | OPKO Health, Inc. | 1.14B | -1.31% | 5,802,030 | 581.12M |
| 364 | CGEM | Cullinan Therapeutics, Inc. | 1.13B | 0.11% | 693,854 | - |
| 365 | BIOA | BioAge Labs, Inc. | 1.11B | 5.01% | 702,025 | 10.32M |
| 366 | LMRI | Lumexa Imaging Holdings, Inc. | 1.10B | -5.00% | 811,482 | 1.03B |
| 367 | WVE | Wave Life Sciences Ltd. | 1.09B | -2.57% | 2,686,980 | 71.80M |
| 368 | AORT | Artivion, Inc. | 1.09B | -5.17% | 800,665 | 458.69M |
| 369 | TNDM | Tandem Diabetes Care, Inc. | 1.08B | -2.52% | 1,146,901 | 1.03B |
| 370 | OLMA | Olema Pharmaceuticals, Inc. | 1.07B | 7.11% | 1,441,894 | - |
| 371 | ORIC | ORIC Pharmaceuticals, Inc. | 1.05B | 6.56% | 1,115,124 | - |
| 372 | CRON | Cronos Group Inc. | 1.05B | 1.42% | 897,819 | 159.54M |
| 373 | USPH | U.S. Physical Therapy, Inc. | 1.05B | 0.06% | 211,148 | 787.69M |
| 374 | CNMD | CONMED Corporation | 1.04B | -4.28% | 727,285 | 1.37B |
| 375 | SANA | Sana Biotechnology, Inc. | 1.03B | 0.88% | 2,209,707 | - |
| 376 | DRTS | Alpha Tau Medical Ltd. | 1.01B | 3.12% | 874,072 | - |
| 377 | AVTX | Avalo Therapeutics, Inc. | 1.01B | 5.55% | 1,578,079 | 59.00K |
| 378 | EVO | Evotec SE | 1.01B | 1.82% | 55,550 | 859.03M |
| 379 | VOR | Vor Biopharma Inc. | 1.01B | 15.53% | 2,808,951 | - |
| 380 | ETON | Eton Pharmaceuticals, Inc. | 1.01B | 2.89% | 665,083 | 86.93M |
| 381 | CERT | Certara, Inc. | 989.39M | 8.90% | 4,636,418 | 419.75M |
| 382 | PCRX | Pacira BioSciences, Inc. | 987.24M | -0.59% | 388,893 | 734.86M |
| 383 | ANRO | Alto Neuroscience, Inc. | 985.09M | 3.81% | 643,306 | - |
| 384 | KURA | Kura Oncology, Inc. | 973.85M | 0.64% | 1,164,715 | 71.64M |
| 385 | DBVT | DBV Technologies S.A. | 967.91M | -0.06% | 506,758 | 5.74M |
| 386 | GDRX | GoodRx Holdings, Inc. | 965.22M | 1.79% | 1,239,478 | 787.89M |
| 387 | AVR | Anteris Technologies Global Corp. | 952.01M | 0.93% | 1,339,918 | 1.85M |
| 388 | PHAR | Pharming Group N.V. | 947.75M | 0.37% | 8,298 | 369.49M |
| 389 | LBRX | LB Pharmaceuticals Inc | 936.01M | 2.26% | 367,085 | - |
| 390 | JANX | Janux Therapeutics, Inc. | 933.98M | 2.51% | 1,191,054 | 13.73M |
| 391 | INMD | InMode Ltd. | 933.91M | 0.75% | 562,095 | 374.64M |
| 392 | SLDB | Solid Biosciences Inc. | 932.32M | 1.94% | 1,704,696 | - |
| 393 | REPL | Replimune Group, Inc. | 924.81M | -3.70% | 3,717,171 | - |
| 394 | ABUS | Arbutus Biopharma Corporation | 924.48M | 2.18% | 2,502,591 | 191.45M |
| 395 | AMPH | Amphastar Pharmaceuticals, Inc. | 917.13M | -4.50% | 727,053 | 720.53M |
| 396 | ANNX | Annexon, Inc. | 912.60M | 1.64% | 8,329,757 | - |
| 397 | ODTX | Odyssey Therapeutics, Inc. | 904.42M | 4.26% | 388,824 | 1.06M |
| 398 | DSGN | Design Therapeutics, Inc. | 889.39M | 6.67% | 1,493,998 | - |
| 399 | TBPH | Theravance Biopharma, Inc. | 880.27M | -3.15% | 3,124,786 | 109.78M |
| 400 | AGMB | AgomAb Therapeutics NV | 877.60M | 29.04% | 198,263 | - |
| 401 | TALK | Talkspace, Inc. | 871.07M | -0.38% | 1,844,362 | 238.37M |
| 402 | PHAT | Phathom Pharmaceuticals, Inc. | 863.41M | 1.40% | 984,782 | 204.89M |
| 403 | SPRY | ARS Pharmaceuticals, Inc. | 850.04M | 0.23% | 1,407,104 | 98.99M |
| 404 | GERN | Geron Corporation | 833.98M | -1.52% | 14,543,025 | 196.12M |
| 405 | ZVRA | Zevra Therapeutics, Inc. | 828.20M | 3.62% | 1,434,182 | 122.29M |
| 406 | BVS | Bioventus Inc. | 816.97M | - | 582,718 | 576.30M |
| 407 | CTMX | CytomX Therapeutics, Inc. | 814.21M | 10.00% | 5,818,626 | 35.54M |
| 408 | ESPR | Esperion Therapeutics, Inc. | 812.20M | -0.63% | 5,477,270 | 418.24M |
| 409 | GMRS | GMR Solutions Inc. | 795.05M | 1.31% | 812,674 | 5.83B |
| 410 | HSTM | HealthStream, Inc. | 792.61M | 1.50% | 206,476 | 311.78M |
| 411 | OCS | Oculis Holding AG | 790.48M | 9.08% | 648,863 | 1.40M |
| 412 | ALLO | Allogene Therapeutics, Inc. | 766.24M | 4.23% | 13,253,414 | 22.00K |
| 413 | CLYM | Climb Bio, Inc. | 765.00M | 2.14% | 1,158,525 | - |
| 414 | IVA | Inventiva S.A. | 761.81M | 4.11% | 933,860 | 7.94M |
| 415 | CADL | Candel Therapeutics, Inc. | 759.08M | 5.82% | 1,481,717 | - |
| 416 | AURA | Aura Biosciences, Inc. | 758.86M | -1.71% | 311,032 | - |
| 417 | BBNX | Beta Bionics, Inc. | 757.55M | 1.07% | 715,267 | 110.24M |
| 418 | CBLL | CeriBell, Inc. | 757.34M | -0.10% | 235,498 | 95.07M |
| 419 | NVCT | Nuvectis Pharma, Inc. | 756.77M | 4.93% | 473,822 | - |
| 420 | SIBN | SI-BONE, Inc. | 749.28M | -2.51% | 487,295 | 206.22M |
| 421 | IMMX | Immix Biopharma, Inc. | 746.78M | 5.11% | 1,853,286 | - |
| 422 | CSTL | Castle Biosciences, Inc. | 739.75M | 0.37% | 295,568 | 339.92M |
| 423 | RLMD | Relmada Therapeutics, Inc. | 732.13M | 4.33% | 2,311,664 | - |
| 424 | SGP | SpyGlass Pharma, Inc. | 723.83M | 2.22% | 104,361 | - |
| 425 | RIGL | Rigel Pharmaceuticals, Inc. | 722.32M | 0.90% | 283,617 | 299.77M |
| 426 | OMER | Omeros Corporation | 717.24M | 14.30% | 2,573,642 | 9.89M |
| 427 | IRWD | Ironwood Pharmaceuticals, Inc. | 707.84M | 4.12% | 3,499,406 | 361.51M |
| 428 | ACRS | Aclaris Therapeutics, Inc. | 701.11M | 0.40% | 1,838,657 | 8.37M |
| 429 | TENX | Tenax Therapeutics, Inc. | 689.74M | 0.45% | 641,660 | - |
| 430 | EIKN | Eikon Therapeutics, Inc. | 689.73M | 11.27% | 459,916 | - |
| 431 | SSII | SS Innovations International, Inc. | 688.45M | 2.99% | 22,052 | 48.47M |
| 432 | TCMD | Tactile Systems Technology, Inc. | 683.23M | 0.03% | 244,531 | 343.52M |
| 433 | FDMT | 4D Molecular Therapeutics, Inc. | 673.32M | 11.03% | 1,522,324 | 88.24M |
| 434 | PRME | Prime Medicine, Inc. | 671.90M | 8.45% | 5,288,695 | 4.03M |
| 435 | DNA | Ginkgo Bioworks Holdings, Inc. | 666.96M | -0.39% | 1,315,455 | 151.40M |
| 436 | EVH | Evolent Health, Inc. | 649.02M | 4.72% | 2,647,108 | 1.89B |
| 437 | ACHV | Achieve Life Sciences, Inc. | 639.57M | 3.49% | 2,028,238 | - |
| 438 | PHR | Phreesia, Inc. | 636.04M | 2.18% | 1,330,146 | 495.59M |
| 439 | MNPR | Monopar Therapeutics Inc. | 633.44M | 7.85% | 119,867 | - |
| 440 | TECX | Tectonic Therapeutic, Inc. | 623.63M | 3.31% | 256,801 | - |
| 441 | DRUG | Bright Minds Biosciences Inc. | 619.56M | 5.15% | 334,867 | - |
| 442 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 613.62M | 3.65% | 235,796 | - |
| 443 | RGNX | REGENXBIO Inc. | 611.58M | 12.88% | 2,541,685 | 87.82M |
| 444 | FTH | Faeth Therapeutics, Inc. | 601.29M | 1.99% | 66,198 | - |
| 445 | CRMD | CorMedix Inc. | 600.94M | -2.68% | 1,282,713 | 400.05M |
| 446 | CERS | Cerus Corporation | 599.10M | 2.40% | 2,007,280 | 216.56M |
| 447 | CBIO | Crescent Biopharma, Inc. | 598.12M | -3.02% | 430,465 | 11.88M |
| 448 | NNNN | Anbio Biotechnology | 594.73M | -6.74% | 34,612 | 8.65M |
| 449 | TRAX | First Tracks Biotherapeutics, Inc. | 591.77M | 5.80% | 331,108 | - |
| 450 | GYRE | Gyre Therapeutics, Inc. | 591.63M | 2.94% | 79,749 | 117.05M |
| 451 | BWAY | BrainsWay Ltd. | 589.85M | 4.70% | 112,936 | 56.22M |
| 452 | FLGT | Fulgent Genetics, Inc. | 583.06M | 2.86% | 294,585 | 320.35M |
| 453 | CLPT | ClearPoint Neuro, Inc. | 582.70M | 5.14% | 821,300 | 40.61M |
| 454 | MDXG | MiMedx Group, Inc. | 582.38M | -0.51% | 1,299,925 | 389.42M |
| 455 | CTEV | Claritev Corporation | 576.56M | 2.02% | 134,690 | 978.76M |
| 456 | ALT | Altimmune, Inc. | 571.75M | 4.26% | 3,632,216 | 36.00K |
| 457 | PROK | ProKidney Corp. | 570.89M | 3.28% | 1,433,075 | 889.00K |
| 458 | OCGN | Ocugen, Inc. | 565.33M | 11.33% | 13,421,865 | 4.47M |
| 459 | NPCE | NeuroPace, Inc. | 563.57M | 0.36% | 160,944 | 99.53M |
| 460 | CTKB | Cytek Biosciences, Inc. | 561.77M | -2.90% | 1,147,685 | 204.17M |
| 461 | CTNM | Contineum Therapeutics, Inc. | 560.38M | 5.63% | 447,552 | - |
| 462 | TOI | The Oncology Institute, Inc. | 559.90M | 3.90% | 2,643,829 | 545.76M |
| 463 | MYGN | Myriad Genetics, Inc. | 552.52M | -0.51% | 1,928,736 | 829.00M |
| 464 | STRO | Sutro Biopharma, Inc. | 551.30M | 9.01% | 464,169 | 99.61M |
| 465 | ANGO | AngioDynamics, Inc. | 550.20M | -1.49% | 282,534 | 313.73M |
| 466 | TLRY | Tilray Brands, Inc. | 549.89M | -0.65% | 3,330,930 | 858.28M |
| 467 | SLBT | SL Science Holding Limited | 549.53M | -9.33% | 218,073 | - |
| 468 | EVMN | Evommune, Inc. | 542.08M | -40.23% | 10,243,268 | 10.00M |
| 469 | PACB | Pacific Biosciences of California, Inc. | 537.34M | 4.85% | 7,976,627 | 160.03M |
| 470 | ARVN | Arvinas, Inc. | 534.88M | 3.62% | 954,110 | 89.40M |
| 471 | ZURA | Zura Bio Limited | 534.84M | 5.23% | 2,445,448 | - |
| 472 | ASMB | Assembly Biosciences, Inc. | 534.07M | 0.79% | 235,468 | 71.10M |
| 473 | KYTX | Kyverna Therapeutics, Inc. | 533.78M | 4.03% | 1,375,284 | - |
| 474 | RZLT | Rezolute, Inc. | 532.78M | 1.19% | 1,202,014 | - |
| 475 | XOMA | XOMA Royalty Corporation | 528.60M | - | 368,062 | 48.56M |
| 476 | STTK | Shattuck Labs, Inc. | 525.26M | 6.37% | 1,943,729 | 1.00M |
| 477 | FBRX | Forte Biosciences, Inc. | 522.43M | 1.66% | 473,387 | - |
| 478 | PRTA | Prothena Corporation plc | 521.96M | -0.50% | 327,420 | 57.94M |
| 479 | AQST | Aquestive Therapeutics, Inc. | 521.87M | -5.24% | 3,292,933 | 50.27M |
| 480 | KIDS | OrthoPediatrics Corp. | 515.75M | -1.08% | 181,843 | 243.30M |
| 481 | NGNE | Neurogene Inc. | 510.09M | 0.78% | 544,568 | 925.00K |
| 482 | SLN | Silence Therapeutics plc | 509.65M | 6.41% | 1,133,924 | 839.00K |
| 483 | OVID | Ovid Therapeutics Inc. | 507.66M | 6.67% | 1,324,322 | 7.12M |
| 484 | CABA | Cabaletta Bio, Inc. | 507.10M | 2.30% | 5,531,382 | - |
| 485 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 486 | SOPH | SOPHiA GENETICS SA | 502.53M | 4.17% | 317,523 | 81.18M |
| 487 | EDIT | Editas Medicine, Inc. | 491.08M | 12.28% | 3,036,909 | 38.69M |
| 488 | WEAV | Weave Communications, Inc. | 487.74M | 3.55% | 1,340,550 | 248.72M |
| 489 | NRC | NRC Health | 487.69M | 3.99% | 67,084 | 138.64M |
| 490 | PRLD | Prelude Therapeutics Incorporated | 485.97M | 11.87% | 473,762 | 16.72M |
| 491 | VALN | Valneva SE | 482.77M | -0.39% | 36,780 | 180.25M |
| 492 | SGMT | Sagimet Biosciences Inc. | 481.05M | 10.34% | 1,348,991 | - |
| 493 | CCCC | C4 Therapeutics, Inc. | 480.97M | 2.11% | 3,114,979 | 34.86M |
| 494 | MOBI | Mobia Medical, Inc. | 478.12M | -1.71% | 143,852 | 38.45M |
| 495 | EOLS | Evolus, Inc. | 469.54M | - | 669,566 | 301.79M |
| 496 | ARTV | Artiva Biotherapeutics, Inc. | 465.47M | -0.42% | 348,773 | 251.00K |
| 497 | CYH | Community Health Systems, Inc. | 459.19M | 3.35% | 1,059,844 | 12.29B |
| 498 | ANL | Adlai Nortye Ltd. | 456.40M | 14.10% | 203,314 | 5.00M |
| 499 | SRTA | Strata Critical Medical, Inc. | 448.21M | -2.26% | 1,129,414 | 228.58M |
| 500 | DCTH | Delcath Systems, Inc. | 447.06M | 0.08% | 640,444 | 90.44M |